200 related articles for article (PubMed ID: 21787230)
1. Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells.
Kim SY; Kim MJ; Jung H; Kim WK; Kwon SO; Son MJ; Jang IS; Choi JS; Park SG; Park BC; Han YM; Lee SC; Cho YS; Bae KH
Stem Cells Dev; 2012 May; 21(8):1272-86. PubMed ID: 21787230
[TBL] [Abstract][Full Text] [Related]
2. Combining membrane proteomics and computational three-way pathway analysis revealed signalling pathways preferentially regulated in human iPSCs and human ESCs.
Tien WS; Chen PM; Chuang CY; Lui SM; Kuo HC; Chen YJ; Wu KP
Sci Rep; 2017 Nov; 7(1):15055. PubMed ID: 29118436
[TBL] [Abstract][Full Text] [Related]
3. An orthogonal comparison of the proteome of human embryonic stem cells with that of human induced pluripotent stem cells of different genetic background.
Faradonbeh MZ; Gharechahi J; Mollamohammadi S; Pakzad M; Taei A; Rassouli H; Baharvand H; Salekdeh GH
Mol Biosyst; 2012 Jun; 8(6):1833-40. PubMed ID: 22543856
[TBL] [Abstract][Full Text] [Related]
4. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
5. Defining pluripotent stem cells through quantitative proteomic analysis.
Reiland S; Salekdeh GH; Krijgsveld J
Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
7. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers.
Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S
BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259
[TBL] [Abstract][Full Text] [Related]
8. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells.
Ghosh Z; Wilson KD; Wu Y; Hu S; Quertermous T; Wu JC
PLoS One; 2010 Feb; 5(2):e8975. PubMed ID: 20126639
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming- and pluripotency-associated membrane proteins in mouse stem cells revealed by label-free quantitative proteomics.
Hao J; Li W; Dan J; Ye X; Wang F; Zeng X; Wang L; Wang H; Cheng Y; Liu L; Shui W
J Proteomics; 2013 Jun; 86():70-84. PubMed ID: 23615220
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomics of protein complexes and their implications for cell reprograming and pluripotency.
Sudhir PR; Kumari MP; Hsu WT; Massiot J; Chen CH; Kuo HC; Chen CH
J Proteome Res; 2013 Dec; 12(12):5878-90. PubMed ID: 24256468
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
12. Human and mouse induced pluripotent stem cells are differentially reprogrammed in response to kinase inhibitors.
Hirano K; Nagata S; Yamaguchi S; Nakagawa M; Okita K; Kotera H; Ainscough J; Tada T
Stem Cells Dev; 2012 May; 21(8):1287-98. PubMed ID: 21882976
[TBL] [Abstract][Full Text] [Related]
13. Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential.
Marei HE; Althani A; Lashen S; Cenciarelli C; Hasan A
Sci Rep; 2017 Dec; 7(1):17504. PubMed ID: 29235536
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
[TBL] [Abstract][Full Text] [Related]
15. TaqMan® OpenArray® high-throughput transcriptional analysis of human embryonic and induced pluripotent stem cells.
Patel SN; Wu Y; Bao Y; Mancebo R; Au-Young J; Grigorenko E
Methods Mol Biol; 2013; 997():191-201. PubMed ID: 23546757
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
Jozefczuk J; Prigione A; Chavez L; Adjaye J
Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
[TBL] [Abstract][Full Text] [Related]
17. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis.
Pripuzova NS; Getie-Kebtie M; Grunseich C; Sweeney C; Malech H; Alterman MA
Stem Cell Res; 2015 May; 14(3):323-38. PubMed ID: 25840413
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation dynamics in human induced pluripotent stem cells.
Nishino K; Umezawa A
Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573
[TBL] [Abstract][Full Text] [Related]
19. Proteomic Analysis of Mouse Oocytes Identifies PRMT7 as a Reprogramming Factor that Replaces SOX2 in the Induction of Pluripotent Stem Cells.
Wang B; Pfeiffer MJ; Drexler HC; Fuellen G; Boiani M
J Proteome Res; 2016 Aug; 15(8):2407-21. PubMed ID: 27225728
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O/18O labeling.
Huang X; Tian C; Liu M; Wang Y; Tolmachev AV; Sharma S; Yu F; Fu K; Zheng J; Ding SJ
J Proteome Res; 2012 Apr; 11(4):2091-102. PubMed ID: 22375802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
